Is Cresco Labs Inc. (CRLBF) a Buy, Sell, or Hold?
OTC : CRLBF
Cresco Labs Inc.
$0.7115 USD
-$0.01 (-0.77%)
- Volume
- 80.41K
- Average Volume
- 750.31K
- Market Capitalization
- $252.03M
- P/E Ratio
- -1.78
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $2.30
- Year Low
- $0.54
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.51
Company Overview
OTC
Charles Bachtell
Drug Manufacturers - Specialty & Generic
Healthcare
CRLBF
2900
US
USD
Liquidity Metrics
1.75
2.51
1.41
0.65
0.00
Sales & Valuation
$667.33M
0.39
0.77
-1147.08
0.00
Profitability
-$0.39
-$137.78M
-21.28%
-15.36%
-35.26%
-11.36%
P/E Metrics
-1.78
0.01
0.01
Analyst Price Target & Rating
$5.50
$8.50
$2.50
2/5
7 Analysts
-87.06%
Financial Health Scores
-0.77
2/9
$148.99M
$1.2B
$957.79M
$54.63M
Key Metrics (TTM)
$779.97M
1.22
7.21
2.51
-35.26%
5.92%
-52.09%
-0.09%
126 days
Company Executives
| Name | Title |
|---|---|
| Gregory Butler | President |
| Angie Demchenko | Chief People Officer |
| Sharon Schuler | Chief Financial Officer |
| Ty Gent | Chief Operating Officer |
| Zach Marburger | Chief Information Officer |
| John Schetz | General Counsel |
| Charles Bachtell | Co-Founder, Chief Executive Officer & Director |
| Joseph Ales | Senior Vice President of Operations |
| Robert Sampson | Co-Founder & Independent Director |
| Cole | Senior Vice President of Corporate Development and Investor Relations |
Poll Results
No votes yet today — be the first to share your view!
About Cresco Labs Inc. (OTC:CRLBF) Stock
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL. ...
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-13 06:30:00
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with ke.
Looking for Cannabis Growth? Watch These 3 Marijuana Stocks in July 2026
2026-06-30 10:00:44
The cannabis industry continues evolving as operators focus on profitability, stronger balance sheets, and strategic expansion. At the same time, federal cannabis reform discussions have improved investor sentiment. Many companies are also positioning themselves for future regulatory changes. As a result, investors are paying closer attention to established multi-state operators with recognizable brands and expanding retail footprints.
Top Cannabis Companies Building Momentum in June 2026
2026-06-16 10:00:39
The cannabis industry continues to evolve across the United States. Several operators are expanding their retail footprints while improving profitability. At the same time, investors are watching for regulatory changes that could support future growth. As a result, leading multi-state operators remain popular among cannabis-focused investors.
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
2026-06-11 09:16:04
CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
2026-06-08 06:00:00
CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
2026-05-27 06:30:00
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances.
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
2026-05-11 13:01:18
Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety
2026-05-11 06:30:00
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) has announced a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced.
Frequently Asked Questions
-
What is the current Cresco Labs Inc. (CRLBF) stock price?
-
Cresco Labs Inc.(OTC:CRLBF) stock price is $0.7115 in the last trading session. During the trading session, CRLBF stock reached the peak price of $2.3 while $0.535 was the lowest point it dropped to. The percentage change in CRLBF stock occurred in the recent session was --0.77% while the dollar amount for the price change in CRLBF stock was -$0.01.
-
CRLBF's industry and sector of operation?
-
The OTC listed CRLBF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of CRLBF?
-
Gregory Butler | President
Angie Demchenko | Chief People Officer
Sharon Schuler | Chief Financial Officer
Ty Gent | Chief Operating Officer
Zach Marburger | Chief Information Officer -
How many employees does CRLBF have?
-
Number of CRLBF employees currently stands at 2900. CRLBF operates from 600 W. Fulton Street, Chicago, IL 60661, US.
-
Link for CRLBF official website?
-
Official Website of CRLBF is: https://www.crescolabs.com
-
How do I contact CRLBF?
-
CRLBF could be contacted at phone #312 929 0993 and can also be accessed through its website. CRLBF operates from 600 W. Fulton Street, Chicago, IL 60661, US.
-
How many shares of CRLBF are traded daily?
-
The average number of CRLBF shares traded daily for last 3 months was 750.31K.
-
What is the market cap of CRLBF currently?
-
The market value of CRLBF currently stands at $252.03M with its latest stock price at $0.7115